Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild-to-moderate COVID-19”

161 trials

Showing 20 of 161 results

Testing effectiveness (Phase 2)Study completedNCT04475107
What this trial is testing

The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients

Who this might be right for
COVID-19
Shin Poong Pharmaceutical Co. Ltd. 113
Early research (Phase 1)Ended earlyNCT05386472
What this trial is testing

Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19

Who this might be right for
COVID-19
Pfizer 25
Testing effectiveness (Phase 2)Study completedNCT05752175
What this trial is testing

Study of WPV01 Compared With Placebo in Patients With Mild/Moderate COVID-19 Infection

Who this might be right for
COVID-19 Infection
Westlake Pharmaceuticals (Hangzhou) Co., Ltd. 80
Large-scale testing (Phase 3)Ended earlyNCT04504734
What this trial is testing

Bucillamine in Treatment of Patients With COVID-19

Who this might be right for
Covid19
Revive Therapeutics, Ltd. 713
Large-scale testing (Phase 3)Study completedNCT05341609
What this trial is testing

Efficacy and Safety of JT001 (VV116) Compared With Paxlovid

Who this might be right for
COVID-19
Vigonvita Life Sciences 822
Large-scale testing (Phase 3)Ended earlyNCT04521296
What this trial is testing

Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo

Who this might be right for
Mild to Moderate COVID-19
Daewoong Pharmaceutical Co. LTD. 432
Large-scale testing (Phase 3)Temporarily pausedNCT04252664
What this trial is testing

A Trial of Remdesivir in Adults With Mild and Moderate COVID-19

Who this might be right for
COVID-19SARS-CoV-2
Capital Medical University 308
Large-scale testing (Phase 3)Ended earlyNCT04869228
What this trial is testing

Randomized, Double-Blind Placebo Controlled, Multi-regional Trial to Evaluate the Efficacy and Safety of GT0918 for the Treatment of Mild to Moderate COVID-19 Male Patients

Who this might be right for
COVID-19
Suzhou Kintor Pharmaceutical Inc, 380
Large-scale testing (Phase 3)UnknownNCT04355052
What this trial is testing

Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to "no Treatment" in SARS CoV 2 Virus

Who this might be right for
COVID - 19
Sheba Medical Center 250
Large-scale testing (Phase 3)Ended earlyNCT04523090
What this trial is testing

Catalysing the Containment of COVID-19

Who this might be right for
COVID-19
University of Cape Town 322
Large-scale testing (Phase 3)Study completedNCT04486313
What this trial is testing

Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19

Who this might be right for
COVID-19
Romark Laboratories L.C. 935
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07664696
What this trial is testing

Evaluation of the Safety and Efficacy of XoGlo Pro, a Placental Mesenchymal Stem Cell-derived Extracellular Vesicles in Treating COVID-19 Symptoms

Who this might be right for
COVID-19
Kimera Labs Inc. 64
Not applicableStudy completedNCT04621903
What this trial is testing

A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-Moderate COVID-19

Who this might be right for
Covid19
Aarogyam UK 26
Testing effectiveness (Phase 2)Looking for participantsNCT07157007
What this trial is testing

Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID - 19
Traws Pharma, Inc. 90
Early research (Phase 1)Ended earlyNCT05184218
What this trial is testing

Evaluation of IGM-6268 in Healthy Adults and Patients With Mild to Moderate COVID-19

Who this might be right for
Healthy VolunteersCOVID-19
IGM Biosciences, Inc. 26
Large-scale testing (Phase 3)UnknownNCT04467918
What this trial is testing

CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms

Who this might be right for
SARS-CoV2
University of Sao Paulo 100
Not applicableStudy completedNCT04681079
What this trial is testing

Comparison of Viral Particle Dispersion Following Administration of an MDI or Nebulizer in Subjects With COVID-19

Who this might be right for
COVID-19
Theravance Biopharma 14
Not applicableStudy completedNCT04486482
What this trial is testing

A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function

Who this might be right for
Mild-to-Moderate COVID-19
Kaleido Biosciences 49
Testing effectiveness (Phase 2)Ended earlyNCT05381363
What this trial is testing

Inhaled Interferon α2b Treatment in Mild-to-moderate COVID-19 Infected Children

Who this might be right for
COVID-19Children
Children's Hospital of Fudan University 24
Large-scale testing (Phase 3)Study completedNCT05656443
What this trial is testing

Study of GST-HG171/Ritonavir Compared With Placebo in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19 Pneumonia
Fujian Akeylink Biotechnology Co., Ltd. 1,246
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation